|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
2
|
Shimada K, Sakamoto Y, Sano T and Kosuge
T: Prognostic factors after distal pancreatectomy with extended
lymphadenectomy for invasive pancreatic adenocarcinoma of the body
and tail. Surgery. 139:288–295. 2006. View Article : Google Scholar
|
|
3
|
Wagner M, Redaelli C, Lietz M, Seiler CA,
Friess H and Buchler MW: Curative resection is the single most
important factor determining outcome in patients with pancreatic
adenocarcinoma. Br J Surg. 91:586–594. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar
|
|
5
|
Longley DB, Harkin DP and Johnston PG:
5-fluorouracil: mechanisms of action and clinical strategies. Nat
Rev Cancer. 3:330–338. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jr Aguiar S , Lopes A, Soares FA, Rossi
BM, et al: Prognostic and predictive value of the thymidylate
synthase expression in patients with non-metastatic colorectal
cancer. Eur J Surg Oncol. 31:863–868. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Edler D, Glimelius B, Hallström M, et al:
Thymidylate synthase expression in colorectal cancer: a prognostic
and predictive marker of benefit from adjuvant fluorouracil-based
chemotherapy. J Clin Oncol. 20:1721–1728. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Formentini A, Henne-Bruns D and Kornmann
M: Thymidylate synthase expression and prognosis of patients with
gastrointestinal cancers receiving adjuvant chemotherapy: a review.
Langenbecks Arch Surg. 389:405–413. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van der Zee JA, van Eijck CH, Hop WC, et
al: Expression and prognostic significance of thymidylate synthase
(TS) in pancreatic head and periampullary cancer. Eur J Surg Oncol.
38:1058–1064. 2012.PubMed/NCBI
|
|
10
|
Kondo N, Murakami Y, Uemura K, et al:
Prognostic impact of dihydropyrimidine dehydrogenase expression on
pancreatic adenocarcinoma patients treated with S-1-based adjuvant
chemotherapy after surgical resection. J Surg Oncol. 104:146–154.
2011. View Article : Google Scholar
|
|
11
|
Nakahara O, Takamori H, Tanaka H, et al:
Clinical significance of dihydropyrimidine dehydrogenase and
thymidylate synthase expression in patients with pancreatic cancer.
Int J Clin Oncol. 15:39–45. 2010. View Article : Google Scholar
|
|
12
|
Shimoda M, Sawada T and Kubota K:
Thymidylate synthase and dihydropyrimidine dehydrogenase are
upregulated in pancreatic and biliary tract cancers. Pathobiology.
76:193–198. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu YC, Komorowski RA, Graewin S, et al:
Thymidylate synthase expression predicts the response to
5-fluorouracil-based adjuvant therapy in pancreatic cancer. Clin
Cancer Res. 9:4165–4171. 2003.PubMed/NCBI
|
|
14
|
Tierney JF, Stewart LA, Ghersi D, Burdett
S and Sydes MR: Practical methods for incorporating summary
time-to-event data into meta-analysis. Trials. 8(16)2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lau J, Ioannidis JP and Schmid CH:
Quantitative synthesis in systematic reviews. Ann Intern Med.
127:820–826. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Begg CB and Mazumdar M: Operating
characteristics of a rank correlation test for publication bias.
Biometrics. 50:1088–1101. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takamura M, Nio Y, Yamasawa K, Dong M,
Yamaguchi K and Itakura M: Implication of thymidylate synthase in
the outcome of patients with invasive ductal carcinoma of the
pancreas and efficacy of adjuvant chemotherapy using 5-fluorouracil
or its derivatives. Anticancer Drugs. 13:75–85. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Begg CB and Berlin JA: Publication bias: A
problem in interpreting medical data. J R Stat Soc Ser A.
151:419–463. 1988. View
Article : Google Scholar
|
|
21
|
Pham B, Klassen TP, Lawson ML and Moher D:
Language of publication restrictions in systematic reviews gave
different results depending on whether the intervention was
conventional or complementary. J Clin Epidemiol. 58:769–776. 2005.
View Article : Google Scholar
|
